Granules gets USFDA nod for ADHD treatment drug

New Delhi ;  Drug firm Granules India Monday said its subsidiary has received approval from the US health regulator for Methylphenidate Hydrochloride extended-release capsules, used for the treatment of attention deficit hyperactivity disorder (ADHD). The approved product is bioequivalent to the reference listed drug product (RLD), Ritalin LA extended-release […]